Here, we have provided novel insights on the molecular mechanisms through which estrogenic GPER signaling in both breast cancer cells and CAFs lowers the expression of miR-338-3p, which has been reported to act as an inhibitor of cancer cell growth and invasion [30,31,32,33,34]. This evidence concerns the gene GPER1 and breast carcinoma.